{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:41:33Z","timestamp":1784673693641,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.radonc.2023.109909","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T02:04:43Z","timestamp":1694397883000},"page":"109909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Are 7.5\u00a0Gy\u00d72 fractions more efficient than 6\u00a0Gy\u00d73 in exclusive postoperative endometrial cancer brachytherapy? A clinical and dosimetrical analysis"],"prefix":"10.1016","volume":"189","author":[{"given":"Faegheh","family":"Noorian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Abellana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaowen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9867-481X","authenticated-orcid":false,"given":"Antonio","family":"Herreros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Baltrons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Lancellotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2308-0982","authenticated-orcid":false,"given":"Luca","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0111-9540","authenticated-orcid":false,"given":"Sebastia","family":"Sabater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aureli","family":"Torne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7832-334X","authenticated-orcid":false,"given":"Angeles","family":"Rovirosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.109909_b0005","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3390\/cancers14040906","article-title":"Role of brachytherapy in the postoperative management of endometrial cancer: decision-making analysis among experienced European radiation oncologists","volume":"14","author":"Glatzer","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2023.109909_b0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"Marnitz S et al ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.radonc.2023.109909_b0015","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.brachy.2019.03.001","article-title":"Do vaginal recurrence rates differ among adjuvant vaginal brachytherapy regimens in early-stage endometrial cancer?","volume":"18","author":"Ager","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2023.109909_b0020","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s12094-022-02799-7","article-title":"SEOM-GEICO clinical guidelines on endometrial cancer (2021)","volume":"24","author":"Barretina-Ginesta","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.radonc.2023.109909_b0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.brachy.2016.04.005","article-title":"American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review","volume":"16","author":"Harkenrider","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2023.109909_b0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brachy.2015.09.012","article-title":"Vaginal brachytherapy for postoperative endometrial cancer: 2014 Survey of the American Brachytherapy Society","volume":"15","author":"Harkenrider","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2023.109909_b0035","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2023.109909_b0040","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2023.109909_b0045","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2023.109909_b0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0167-8140(00)00171-7","article-title":"Post-operative high dose rate brachytherapy in patients with low to intermediate risk endometrial cancer","volume":"56","author":"Pearcey","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109909_b0055","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/ijgc-2021-002493","article-title":"Vaginal brachytherapy management of stage I and II endometrial cancer","volume":"32","author":"van den Heerik","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.radonc.2023.109909_b0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ijgo.13866","article-title":"Cancer of the corpus uteri: 2021 update","volume":"155","author":"Koskas","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.radonc.2023.109909_b0065","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0360-3016(90)90094-Z","article-title":"Postoperative vaginal irradiation with high dose rate afterloading technique in endometrial carcinoma stage","volume":"18","author":"Sorbe","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109909_b0070","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.3390\/cancers12103059","article-title":"EQD2(\u03b1\/\u03b2=3) analyses of vaginal complications in exclusive brachytherapy for postoperative endometrial carcinoma","volume":"12","author":"Zhang","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2023.109909_b0075","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s12094-021-02737-z","article-title":"Preliminary results of a vaginal constraint for reducing G2 late vaginal complications after postoperative brachytherapy in endometrial cancer: a prospective analysis","volume":"24","author":"Zhang","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.radonc.2023.109909_b0080","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.brachy.2017.07.003","article-title":"Comparative results of three short brachytherapy schedules as exclusive treatment in postoperative endometrial carcinoma","volume":"16","author":"Rovirosa","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2023.109909_b0085","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0360-3016(02)04578-9","article-title":"Evaluation of the LENT-SOMA scales for the prospective assessment of treatment morbidity in cervical carcinoma","volume":"56","author":"Routledge","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109909_b0090","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109909_b0095","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.brachy.2015.03.001","article-title":"Predictors of vaginal stenosis after intravaginal high-dose-rate brachytherapy for endometrial carcinoma","volume":"14","author":"Park","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2023.109909_b0100","doi-asserted-by":"crossref","first-page":"559","DOI":"10.5114\/jcb.2018.79713","article-title":"Vaginal toxicity after high-dose-rate endovaginal brachytherapy: 20 years of results","volume":"10","author":"Delishaj","year":"2018","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.radonc.2023.109909_b0105","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.brachy.2021.12.001","article-title":"Pilot study to assess sexual function, quality of life (QOL) and change in vaginal dimensions following vaginal brachytherapy (VBT)","volume":"21","author":"Nieto","year":"2022","journal-title":"30Brachytherapy"},{"key":"10.1016\/j.radonc.2023.109909_b0110","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.brachy.2019.08.007","article-title":"The vaginal cylinder: Misunderstood, misused, or trivial? An in-depth dosimetric and multiinstitutional outcome investigation","volume":"18","author":"Guy","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2023.109909_b0115","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ijrobp.2004.12.079","article-title":"Intravaginal high-doserate brachytherapy for Stage I endometrial cancer: A randomized study of two dose-per-fraction levels","volume":"62","author":"Sorbe","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109909_b0120","first-page":"925","article-title":"Vaginal-cuff control and toxicity results of a daily HDR brachytherapy schedule in endometrial cancer patients","volume":"18","author":"R\u00edos","year":"2016","journal-title":"ClinTrans Oncol"},{"key":"10.1016\/j.radonc.2023.109909_b0125","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11547-022-01455-y","article-title":"EROS 2.0 study: evaluation of two interventional radiotherapy (brachytherapy) schedules for endometrial cancer: a comparison of late vaginal toxicity rates","volume":"127","author":"Lancellotta","year":"2022","journal-title":"Radiol Med"},{"key":"10.1016\/j.radonc.2023.109909_b0130","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s12094-019-02255-z","article-title":"Is one brachytherapy fraction of 7 Gy similar to more fractions after external beam irradiation in postoperative endometrial carcinoma?","volume":"22","author":"Zhang","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.radonc.2023.109909_b0135","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.brachy.2019.09.004","article-title":"Economic impact of decreasing the fraction number in vaginal cuff brachytherapy: A direct cost analysis","volume":"19","author":"Zhang","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2023.109909_b0140","article-title":"Vaginal dilator use more than 9 months is a main prognostic factor for reducing G2\u2013late vaginal complications in 3D\u2013vaginal\u2013cuff brachytherapy (interventional radiotherapy)?","author":"Zhang","year":"2023","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.radonc.2023.109909_b0145","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.3802\/jgo.2020.31.e18","article-title":"Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms","volume":"31","author":"Amagami","year":"2020","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.radonc.2023.109909_b0150","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.prro.2022.09.002","article-title":"Radiation Therapy for Endometrial Cancer: An ASTRO clinical practice guideline","volume":"13","author":"Harkenrider","year":"2023","journal-title":"Practical Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109909_b0155","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1120\/jacmp.v17i5.6182","article-title":"Dosimetric impact of cylinder size in high-dose rate vaginal cuff brachytherapy (VCBT) for primary endometrial cancer","volume":"17","author":"Zhang","year":"2016","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2023.109909_b0160","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ijrobp.2010.10.071","article-title":"Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer","volume":"82","author":"Bahng","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109909_b0165","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.radonc.2015.06.018","article-title":"Prospective study of vaginal dilator use adherence and efficacy following radiotherapy","volume":"116","author":"Law","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109909_b0170","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ijrobp.2015.02.029","article-title":"Dosimetric predictors of radiation-induced vaginal stenosis after pelvic radiation therapy for rectal and anal cancer","volume":"92","author":"Son","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023898036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023898036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:26:19Z","timestamp":1759123579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023898036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":34,"alternative-id":["S0167814023898036"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109909","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are 7.5\u00a0Gy\u00d72 fractions more efficient than 6\u00a0Gy\u00d73 in exclusive postoperative endometrial cancer brachytherapy? A clinical and dosimetrical analysis","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109909","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109909"}}